FI873350A0 - Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI873350A0 FI873350A0 FI873350A FI873350A FI873350A0 FI 873350 A0 FI873350 A0 FI 873350A0 FI 873350 A FI873350 A FI 873350A FI 873350 A FI873350 A FI 873350A FI 873350 A0 FI873350 A0 FI 873350A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- dihydropyridine derivatives
- dihydropyridine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89229386A | 1986-08-04 | 1986-08-04 | |
| US89229386 | 1986-08-04 | ||
| US07/064,361 US4868181A (en) | 1986-08-04 | 1987-06-30 | 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
| US6436187 | 1987-06-30 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI873350A0 true FI873350A0 (fi) | 1987-08-03 |
| FI873350A FI873350A (fi) | 1988-02-05 |
| FI91634B FI91634B (fi) | 1994-04-15 |
| FI91634C FI91634C (fi) | 1994-07-25 |
Family
ID=26744430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI873350A FI91634C (fi) | 1986-08-04 | 1987-08-03 | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4868181A (fi) |
| EP (1) | EP0255710A3 (fi) |
| KR (1) | KR930004648B1 (fi) |
| AU (1) | AU617650B2 (fi) |
| DK (1) | DK403287A (fi) |
| FI (1) | FI91634C (fi) |
| HU (1) | HU201925B (fi) |
| IL (1) | IL83413A0 (fi) |
| NO (1) | NO171909C (fi) |
| NZ (1) | NZ221284A (fi) |
| PT (1) | PT85483B (fi) |
| SU (3) | SU1607687A3 (fi) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137889A (en) * | 1983-12-02 | 1992-08-11 | Otsuka Pharmaceutical Co., Ltd. | Dihydropyridine derivatives and process for preparing the same |
| JPS63112560A (ja) * | 1986-10-29 | 1988-05-17 | Green Cross Corp:The | ジヒドロピリジン誘導体 |
| DE3711991A1 (de) * | 1987-04-09 | 1988-10-20 | Bayer Ag | Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE3737341A1 (de) * | 1987-11-04 | 1989-05-18 | Bayer Ag | Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| DE3737340A1 (de) * | 1987-11-04 | 1989-05-24 | Bayer Ag | Neue fluormethoxyphenyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| US5106845A (en) * | 1990-01-10 | 1992-04-21 | Merrell Dow Pharmaceuticals Inc. | Calcium antagonists |
| NZ232396A (en) * | 1989-02-10 | 1991-07-26 | Merrell Dow Pharma | 2-(diphenylalkylamino) -1,3 nn heterocyclic compounds and pharmaceutical compositions |
| US5166148A (en) * | 1990-07-09 | 1992-11-24 | The Du Pont Merck Pharmaceutical Company | 2-amino-1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
| DE4222770A1 (de) * | 1992-07-10 | 1994-01-13 | Bayer Ag | Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine |
| IL109220A0 (en) * | 1993-04-05 | 1994-07-31 | Synaptic Pharma Corp | Dihydropyridines and new uses thereof |
| US5767131A (en) * | 1993-04-05 | 1998-06-16 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| US6211198B1 (en) | 1993-04-05 | 2001-04-03 | Synaptic Pharmaceutical Corporation | Dihydropyridines and new uses thereof |
| DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| US5635503A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Company | Dihydropyridine npy antagonists: piperazine derivatives |
| AU6229099A (en) * | 1998-10-23 | 2000-05-15 | Ajinomoto Co., Inc. | Dihydropyridine derivatives and drug compositions containing the same |
| EP2925739A4 (en) * | 2012-11-28 | 2016-07-27 | Stichting Dienst Landbouwkundi | SUBSTITUTED DIHYDROPYRTOINS FOR PLANTS WITH SOMATIC EMBRYOGENESIS I |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985758A (en) * | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
| DE2752820A1 (de) * | 1977-11-26 | 1979-05-31 | Bayer Ag | Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2841667A1 (de) * | 1978-09-25 | 1980-04-10 | Bayer Ag | Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| JPS57171968A (en) * | 1981-04-17 | 1982-10-22 | Kyowa Hakko Kogyo Co Ltd | 1,4-dihydropyridine derivative |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| ATE50987T1 (de) * | 1982-05-10 | 1990-03-15 | Takeda Chemical Industries Ltd | Dihydropyridinderivate, deren herstellung und verwendung. |
| DE3377352D1 (en) * | 1982-06-03 | 1988-08-18 | Pierrel Spa | Dihydropyridines with an antagonistic activity to calcium, process for their preparation, and pharmaceutical compositions containing them |
| WO1985000169A1 (en) * | 1983-06-21 | 1985-01-17 | Sandoz Ag | 1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them |
| DE3326384A1 (de) * | 1983-07-22 | 1985-01-31 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
| DE3339861A1 (de) * | 1983-11-04 | 1985-05-15 | Bayer Ag, 5090 Leverkusen | Arzneizubereitung enthaltend dihydropyridine |
| JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体およびその製造法 |
| US4755512A (en) * | 1984-04-11 | 1988-07-05 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities |
| JPS6191185A (ja) * | 1984-10-11 | 1986-05-09 | Sumitomo Seiyaku Kk | 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体 |
| AU5312086A (en) * | 1984-12-21 | 1986-07-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New piperazine derivatives |
| GB8503427D0 (en) * | 1985-02-11 | 1985-03-13 | Ici Plc | Basic compounds |
| DE3521761A1 (de) * | 1985-06-19 | 1987-01-02 | Bayer Ag | Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| EP0222702A3 (de) * | 1985-11-06 | 1988-01-07 | Ciba-Geigy Ag | Basische Carbonylverbindungen |
| DE3600596A1 (de) * | 1986-01-11 | 1987-07-16 | Bayer Ag | 4-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE3601397A1 (de) * | 1986-01-18 | 1987-07-23 | Bayer Ag | Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| JP2742074B2 (ja) * | 1988-11-30 | 1998-04-22 | マツダ株式会社 | 浸炭炉 |
-
1987
- 1987-06-30 US US07/064,361 patent/US4868181A/en not_active Expired - Fee Related
- 1987-07-31 NZ NZ221284A patent/NZ221284A/xx unknown
- 1987-08-01 EP EP87111142A patent/EP0255710A3/en not_active Withdrawn
- 1987-08-03 HU HU873549A patent/HU201925B/hu not_active IP Right Cessation
- 1987-08-03 IL IL83413A patent/IL83413A0/xx unknown
- 1987-08-03 NO NO873240A patent/NO171909C/no unknown
- 1987-08-03 SU SU874203187A patent/SU1607687A3/ru active
- 1987-08-03 DK DK403287A patent/DK403287A/da unknown
- 1987-08-03 FI FI873350A patent/FI91634C/fi not_active IP Right Cessation
- 1987-08-03 AU AU76503/87A patent/AU617650B2/en not_active Ceased
- 1987-08-03 KR KR1019870008497A patent/KR930004648B1/ko not_active IP Right Cessation
- 1987-08-04 PT PT85483A patent/PT85483B/pt not_active IP Right Cessation
-
1988
- 1988-11-04 SU SU884356767A patent/SU1650011A3/ru active
- 1988-11-04 SU SU884356789A patent/SU1609452A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| DK403287D0 (da) | 1987-08-03 |
| DK403287A (da) | 1988-02-05 |
| IL83413A0 (en) | 1988-01-31 |
| AU617650B2 (en) | 1991-12-05 |
| EP0255710A2 (en) | 1988-02-10 |
| US4868181A (en) | 1989-09-19 |
| HU201925B (en) | 1991-01-28 |
| SU1650011A3 (ru) | 1991-05-15 |
| SU1609452A3 (ru) | 1990-11-23 |
| EP0255710A3 (en) | 1989-01-04 |
| PT85483B (pt) | 1990-06-29 |
| NO171909B (no) | 1993-02-08 |
| PT85483A (en) | 1987-09-01 |
| NZ221284A (en) | 1989-12-21 |
| FI91634C (fi) | 1994-07-25 |
| KR880002827A (ko) | 1988-05-11 |
| HUT46907A (en) | 1988-12-28 |
| AU7650387A (en) | 1988-02-11 |
| NO171909C (no) | 1993-05-19 |
| FI91634B (fi) | 1994-04-15 |
| FI873350A (fi) | 1988-02-05 |
| KR930004648B1 (ko) | 1993-06-02 |
| NO873240L (no) | 1988-02-05 |
| SU1607687A3 (ru) | 1990-11-15 |
| NO873240D0 (no) | 1987-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| FI874459A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi | |
| FI104170B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi | |
| FI871041A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-disubstituoitujen pyrokatekolijohdannaisten valmistamiseksi | |
| FI890245A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-disubstituoitujen piperidinyylijohdannaisten valmistamiseksi | |
| FI873350A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| FI92696C (fi) | Menetelmä terapeuttisesti käyttökelpoisten tiatsolidiinidionijohdannaisten valmistamiseksi | |
| FI872517A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten makrolidiyhdisteiden valmistamiseksi | |
| FI891339A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi | |
| FI883672A (fi) | Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi | |
| FI880467A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| FI93444B (fi) | Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi | |
| PL268618A1 (en) | The method of manufacture of 1,4-dihydropyridine derivatives | |
| FI893003A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi | |
| FI92064C (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi | |
| PT84959A (en) | Process for the preparation of novel 1,4-dihydropyridines | |
| FI884473A (fi) | Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi | |
| FI892420A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-aminoetanolijohdannaisten valmistamiseksi | |
| PT88158A (pt) | Process for the preparation of a novel diosmin derivative | |
| FI891111A (fi) | Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi | |
| EP0371492A3 (en) | Process for the preparation of 1,4-dihydropyridine derivatives | |
| FI93216C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| FI893434A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi | |
| FI93118B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi | |
| FI92393B (fi) | Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| FD | Application lapsed | ||
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: THE DU PONT MERCK PHARMACEUTICAL COMPANY |